Crizalk 250mg Capsule
- Manufacturer : Pfizer Ltd.
- Composition : Crizotinib 250mg
- Generally Prescribed For : Metastatic Non Small Cell Lung Cancer (NSCLC)
- Estimated Price : ₹81,244.00 For 60 Capsules Bottle
BUY FROM THESE SELLERS
Uses of Crizalk 250mg CapsuleCrizalk 250mg Capsule is used for the treatment or prevention of the following disease(s):
Metastatic Non Small Cell Lung Cancer (NSCLC)
Side effects of Crizalk 250mg CapsuleThe most common side effects of Crizalk 250mg Capsule are - Dizziness, Neuropathy, Headache, Insomnia, Fatigue, Fever, Chest Pain, Edema, Bradycardia, Visual Disorders, Nausea, Diarrhea, Vomiting, Constipation
These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.
Precautions while using Crizalk 250mg CapsuleDo not use Crizalk 250mg Capsule if you are allergic to - Crizotinib
If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Crizalk 250mg Capsule.
If you are allergic to any medicine or food, consult your doctor before using this medicine.
Use this medicine under the supervision of your doctor.
To avoid an adverse reaction, consult your doctor if you are already taking other medicines.
How Crizalk 250mg Capsule worksCrizalk 250mg Capsule contains - Crizotinib
Crizotinib inhibits tyrosine kinase receptors, including ALK and other growth factors, decreasing tumor-cell proliferation.
Dosage of Crizalk 250mg CapsuleThe dosage of Crizalk 250mg Capsule depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.
Please use this medicine as prescribed by your doctor.
Overdose of Crizalk 250mg CapsuleIf you forget to take a dose of Crizalk 250mg Capsule, do not take two doses at the same time, there is a risk of overdose.
If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.
Precautions & Warnings
InteractionDrug :- CYP3A substrates (alfentanil, cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus): May increase levels of these drugs. Avoid use together.
Moderate CYP3A inhibitors (aprepitant, diltiazem, erythromycin, fluconazole, verapamil): May increase crizotinib level. Use together cautiously.
P-glycoprotein substrates (daunorubicin, saquinavir, vinca alkaloids): May increase levels of these drugs. Avoid use together.
Strong CYP3A inducers (carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin): May decrease crizotinib level. Avoid use together.
Strong CYP3A inhibitors (atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, troleandomycin, voriconazole): May increase crizotinib level. Avoid use together.
Herb :- St. John's wort: May decrease crizotinib level. Avoid use together.
Food :- Grapefruit, grapefruit juice: May increase crizotinib level. Avoid use together.